全文获取类型
收费全文 | 4789篇 |
免费 | 522篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 149篇 |
妇产科学 | 70篇 |
基础医学 | 738篇 |
口腔科学 | 87篇 |
临床医学 | 552篇 |
内科学 | 904篇 |
皮肤病学 | 57篇 |
神经病学 | 428篇 |
特种医学 | 256篇 |
外国民族医学 | 1篇 |
外科学 | 518篇 |
综合类 | 194篇 |
一般理论 | 1篇 |
预防医学 | 636篇 |
眼科学 | 64篇 |
药学 | 340篇 |
中国医学 | 21篇 |
肿瘤学 | 288篇 |
出版年
2021年 | 74篇 |
2020年 | 62篇 |
2019年 | 68篇 |
2018年 | 77篇 |
2017年 | 59篇 |
2016年 | 63篇 |
2015年 | 81篇 |
2014年 | 74篇 |
2013年 | 161篇 |
2012年 | 221篇 |
2011年 | 210篇 |
2010年 | 114篇 |
2009年 | 125篇 |
2008年 | 190篇 |
2007年 | 213篇 |
2006年 | 194篇 |
2005年 | 190篇 |
2004年 | 195篇 |
2003年 | 203篇 |
2002年 | 150篇 |
2001年 | 167篇 |
2000年 | 169篇 |
1999年 | 169篇 |
1998年 | 117篇 |
1997年 | 110篇 |
1996年 | 101篇 |
1995年 | 91篇 |
1994年 | 77篇 |
1993年 | 88篇 |
1992年 | 120篇 |
1991年 | 100篇 |
1990年 | 91篇 |
1989年 | 82篇 |
1988年 | 77篇 |
1987年 | 66篇 |
1986年 | 75篇 |
1985年 | 70篇 |
1984年 | 64篇 |
1983年 | 50篇 |
1982年 | 34篇 |
1981年 | 43篇 |
1980年 | 36篇 |
1979年 | 43篇 |
1978年 | 39篇 |
1977年 | 32篇 |
1976年 | 47篇 |
1975年 | 40篇 |
1974年 | 44篇 |
1972年 | 33篇 |
1971年 | 31篇 |
排序方式: 共有5327条查询结果,搜索用时 15 毫秒
41.
42.
Shun Kaneko Masayuki Kurosaki Toshie Mashiba Hiroyuki Marusawa Masahiko Kondo Yuji Kojima Yasushi Uchida Hideki Fujii Takehiro Akahane Hitoshi Yagisawa Atsunori Kusakabe Haruhiko Kobashi Takehiko Abe Hideo Yoshida Chikara Ogawa Koichiro Furuta Nobuharu Tamaki Keiji Tsuji Tomomichi Matsushita Namiki Izumi the Japanese Red Cross Liver Study Group 《Journal of medical virology》2023,95(1):e28210
Nucleos(t)ide analogs (NAs) cannot completely suppress the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). This study aimed to identify the risk factors for HCC development in naïve CHB patients treated with current NA. Patients receiving NA (n = 905) were recruited retrospectively from the 17 hospitals of the Japanese Red Cross Liver Study Group. All treatment-naïve patients had been receiving current NA continuously for more than 1 year until the end of the follow-up. We analyzed the accuracy of predictive risk score using the area under receiver operating characteristic curve. The albumin–bilirubin (ALBI) score was significantly improved by NA therapy (−0.171 ± 0.396; p < 0.001 at Week 48). A total of 72 (8.0%) patients developed HCC over a median follow-up of 6.2 (1.03–15.7) years. An independent predictive factor of HCC development was older age, cirrhosis, lower platelet counts at baseline and ALBI score, and alpha-fetoprotein (AFP) at 1 year after NA therapy according to multivariate analysis. The accuracy was assessed using the PAGE-B, mPAGE-B, aMAP, APA-B, and REAL-B scores that included these factors. Discrimination was generally acceptable for these models. aMAP and REAL-B demonstrated high discrimination with 0.866/0.862 and 0.833/0.859 for 3- and 5-year prediction from the status of 1 year after NA therapy, respectively. Baseline age and platelet count, as well as ALBI and AFP one year after NA, were useful for stratifying carcinogenesis risk. The aMAP and REAL-B scores were validated with high accuracy in Japanese CHB patients. 相似文献
43.
44.
Cross M 《The Health service journal》1997,107(5572):suppl 11-suppl 12
45.
Cross M 《The Health service journal》1997,107(5538):suppl 7-suppl 8
46.
Cross M 《Health data management》1997,5(9):96-99
Virtually every hospital and managed care plan performs credentialing for every physician, and it can be a labor-intensive--and redundant--effort. But administrative software tools are being developed and expanded to better gather and keep track of vital information about physicians. Some providers and health plans are also working together to centralize the process by electronically sharing the information. 相似文献
47.
48.
49.
Cross M 《Health data management》1997,5(10):114-6, 118, 120
The popularity of scheduling software is growing as providers try to find new ways of improving efficiency. That's particularly true at integrated delivery systems, which are seeking to better coordinate care delivery across multiple sites. 相似文献
50.